Power Law company profile

Xiangya Group

Biotech & Life Sciences · Shenzhen, China · Founded 2006 · IPO 2018 Thoroughbred

Xiangya Group is engaged in the research, development, and manufacture of all-natural medicinal and edible healthy food without additives

Valuation

$285M

Market cap · May/2026

Revenue

$347M

Latest reported FY

EBITDA

$49M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Xiangya Group's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Central South University

SAIF Partners

Global footprint

Where Xiangya Group has talent and traffic

Workforce by country

🇨🇳 China · Shenzhen HQ

Book a demo for the full country breakdown

Web traffic by country

180 monthly visits
across markets

🇭🇰 Hong Kong111.1%

Top 1 markets shown

Market sentiment

What the market is saying about Xiangya Group

An AI-synthesized read of the highest-engagement posts about Xiangya Group on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xiangya Group on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles